Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06154200 · ClinicalTrials.gov registry record · Phase 2
Eyelid Androgen Treatment in Dry Eye
A Phase 2 study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT06154200 is a Phase 2 study that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 24 participants.
The verdict
NCT06154200, a Phase 2 study, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effectiveness and safety of applying androgen sex hormone (i.e., testosterone) gel on the eyelids in the treatment of dry eye patients. Several studies have demonstrated positive treatment effects in dry eye, but few have applied testosterone gels to the eyelids.
Interventions
- DRUG Vehicle gel
- DRUG Testosterone gel 4.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-04-02 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06154200
The ClinicalTrials.gov registry entry for NCT06154200 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle gel is the first listed.
NCT06154200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06154200 about?
NCT06154200 is a clinical study titled "Eyelid Androgen Treatment in Dry Eye". The purpose of this research study is to evaluate the effectiveness and safety of applying androgen sex hormone (i.e., testosterone) gel on the eyelids in the treatment of dry eye patients. Several studies have demonstrated positive treatment effects in dry eye, but few have applied testosterone gel...
What is the current status of trial NCT06154200?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2023-04-02. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT06154200?
The interventions under investigation include: Vehicle gel (DRUG), Testosterone gel 4.5% (DRUG).
Who is sponsoring clinical trial NCT06154200?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.